InPoint Commercial Real Estate Income vs Terra Property Trust
ICR.PA and TPTS side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ICR.PA and TPTS compare
Terra Property Trust is the larger company, worth 1.6 times as much as InPoint Commercial Real Estate Income ($310M against $193M).
InPoint Commercial Real Estate Income grew revenue faster over the last twelve months (−11.5% versus −50.3% for Terra Property Trust).
InPoint Commercial Real Estate Income keeps more of each dollar of sales as profit, with a net margin of −69.3% compared with −164% at Terra Property Trust.
Both pay dividends: InPoint Commercial Real Estate Income yields 8.9% and Terra Property Trust 4.6%.
InPoint Commercial Real Estate Income scores higher on the StockData Score (8 against 2 for Terra Property Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ICR.PA | TPTS |
|---|---|---|
| Size and price | ||
| Market cap | $193M | $310M |
| Share price | $19.07 | $12.75 |
| Change, 1 year | −3.7% | – |
| Change, 5 years | −23.1% | – |
| Beta (5Y) | 0.54 | – |
| StockData Score | ||
| Total score | 8 (better) | 2 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 4 (better) | 0 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/S | 8.8× (better) | 14.0× |
| P/B | 0.9× (better) | 2.5× |
| Fair value | $17.74 | $4.89 |
| Margin of safety | −7.5% (better) | −161% |
| Growth | ||
| Revenue growth (TTM) | −11.5% (better) | −50.3% |
| Revenue growth, 5Y average | −0.96% (better) | −6.8% |
| Net income growth (TTM) | −235% | – |
| EPS growth (TTM) | −502% | – |
| Profitability | ||
| Operating margin | – | −75.7% |
| Net margin | −69.3% (better) | −164% |
| Return on equity | −6.7% (better) | −24.6% |
| Return on invested capital | – | −9.5% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −1.8× |
| Altman Z-score | 0.10 (better) | −0.41 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 8.9% (better) | 4.6% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −16.2% |
| Shareholder yield | 8.9% (better) | 4.6% |
| Ownership | ||
| Held by insiders | 0.34% | 0.00% |
| Short interest, % of float | – | 0.00% |
Go deeper
- ICR.PA stock overview
- ICR.PA income statement
- ICR.PA valuation and score
- TPTS stock overview
- TPTS income statement
- TPTS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.